ViaCyte, Inc. Announces FDA Acceptance of IND to Commence Clinical Trial of … – MarketWatch

ViaCyte, Inc. Announces FDA Acceptance of IND to Commence Clinical Trial of ...MarketWatchInstrumental in our ability to achieve this milestone are JDRF, the leading global organization focused on type 1 diabetes (T1D) research, and the California Inst...
http://blog.zandcell.com/viacyte-inc-announces-fda-acceptance-of-ind-to-commence-clinical-trial-of-marketwatch-2/?utm_source=rss&utm_medium=rss&utm_campaign=viacyte-inc-announces-fda-acceptance-of-ind-to-commence-clinical-trial-of-marketwatch-2